Description and role in proliferation of iberiotoxin-sensitive currents in different human mammary epithelial normal and cancerous cells

Biochimica et Biophysica Acta - Biomembranes

Volumn 1667, Issue 2, 2004, Pages 190-199

  Roger, Sébastien ^a   Potier, Marie ^a   Vandier, Christophe ^a   Le Guennec, Jean Yves ^a   Besson, Pierre ^a  

^a Croissance Cancer Equipe Mixte I   (France)

Author keywords

Cancerous; Iberiotoxin; Proliferation

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; ADENOSINE TRIPHOSPHATE; CALCIUM; CALCIUM ACTIVATED POTASSIUM CHANNEL; IBERIOTOXIN;

ARTICLE; BREAST CANCER; CALCIUM CELL LEVEL; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ADENOSINE TRIPHOSPHATE; BENZIMIDAZOLES; BREAST; BREAST NEOPLASMS; CALCIUM; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; ELECTRIC CONDUCTIVITY; EPITHELIUM; FEMALE; FLUORESCENT DYES; FURA-2; HUMANS; KINETICS; MEMBRANE POTENTIALS; PATCH-CLAMP TECHNIQUES; PEPTIDES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS;

EID: 9644301054     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2004.10.002     Document Type: Article

References (27)

1. K.A. Woodfork, W.F. Wonderlin, V.A. Peterson, and J.S. Strobl Inhibition of ATP-sensitive potassium channels causes reversible cell-cycle arrest of human breast cancer cells in tissue culture J. Cell. Physiol. 162 1995 163 171
2. + channel Recept. Channels 7 2001 345 356
3. + channel in MCF-7 human breast carcinoma cells: an apparent correlation of channel incidence with the rate of cell proliferation Pflugers Arch. 417 1991 562 570
4. + channel in normal and cancerous mammary cells in culture J. Membr. Biol. 119 1991 133 139
5. H. Ouadid-Ahidouch, F. Chaussade, M. Roudbaraki, C. Slomianny, E. Dewailly, P. Delcourt, and N. Prevarskaya KV1.1 K(+) channels identification in human breast carcinoma cells: involvement in cell proliferation Biochem. Biophys. Res. Commun. 278 2000 272 277
6. + channels in breast cancer cells: association with cell cycle progression Am. J. Physiol., Cell Physiol. 2004 C125 C134
7. + channels in breast cancer cells Biochem. Biophys. Res. Commun. 316 2004 244 251
8. S. Wang, Z. Melkoumian, K.A. Woodfork, C. Cather, A.G. Davidson, W.F. Wonderlin, and J.S. Strobl Evidence for an early G1 ionic event necessary for cell cycle progression and survival in the MCF-7 human breast carcinoma cell line J. Cell. Physiol. 176 1998 456 464
9. J.S. Strobl, W.F. Wonderlin, and D.C. Flynn Mitogenic signal transduction in human breast cancer cells Gen. Pharmacol. 26 1995 1643 1649
10. W.F. Wonderlin, and J.S. Strobl Potassium channels, proliferation and G1 progression J. Membr. Biol. 154 1996 91 107
11. 2+]i in isolated guinea pig ventricular myocytes Cardiovasc. Res. 28 1994 1193 1198
12. R.E. Godt, and B.D. Lindley Influence of temperature upon contractile activation and isometric force production in mechanically skinned muscle fibers of the frog J. Gen. Physiol. 80 1982 279 297
13. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
14. S. Roger, P. Besson, and J.Y. Le Guennec Involvement of a novel fast inward sodium current in the invasion capacity of a breast cancer cell line Biochim. Biophys. Acta 1616 2003 107 111
15. A. Galvez, G. Gimenez-Gallego, J.P. Reuben, L. Roy-Contancin, P. Feigenbaum, G.J. Kaczorowski, and M.L. Garcia Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus J. Biol. Chem. 265 1990 11083 11090
16. + channels by novel benzimidazolone Eur. J. Pharmacol. 251 1994 53 59
17. S. Roger, J.Y. Guennec, and P. Besson Particular sensitivity to calcium channel blockers of the fast inward voltage-dependent sodium current involved in the invasive properties of a metastastic breast cancer cell line Br. J. Pharmacol. 141 2004 610 615
18. M. Flezar, and S. Heisler P2-purinergic receptors in human breast tumor cells: coupling of intracellular calcium signaling to anion secretion J. Pharmacol. Exp. Ther. 265 1993 1499 1510
19. B. Vandewalle, L. Hornez, F. Revillion, and J. Lefebvre Effect of extracellular ATP on breast tumor cell growth, implication of intracellular calcium Cancer Lett. 85 1994 47 54
20. C.J. Dixon, W.B. Bowler, P. Fleetwood, A.F. Ginty, J.A. Gallagher, and J.A. Carron Extracellular nucleotides stimulate proliferation in MCF-7 breast cancer cells via P2-purinoceptors Br. J. Cancer 75 1997 34 39
21. S.C. Wagstaff, W.B. Bowler, J.A. Gallagher, and R.A. Hipskind Extracellular ATP activates multiple signalling pathways and potentiates growth factor-induced c-fos gene expression in MCF-7 breast cancer cells Carcinogenesis 21 2000 2175 2181
22. D. Mu, L. Chen, X. Zhang, L.H. See, C.M. Koch, C. Yen, J.J. Tong, L. Spiegel, K.C. Nguyen, A. Servoss, Y. Peng, L. Pei, J.R. Marks, S. Lowe, T. Hoey, L.Y. Jan, W.R. McCombie, M.H. Wigler, and S. Powers Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene Cancer Cell 3 2003 297 302
23. C.B. Ransom, X. Liu, and H. Sontheimer BK channels in human glioma cells have enhanced calcium sensitivity Glia 38 2002 281 291
24. R. Kraft, P. Krause, S. Jung, D. Basrai, L. Liebmann, J. Bolz, and S. Patt BK channel openers inhibit migration of human glioma cells Pflugers Arch. 446 2003 248 255
25. G. Edwards, A. Niederste-Hollenberg, J. Schneider, T. Noack, and A.H. Weston Ion channel modulation by NS 1619, the putative BKCa channel opener, in vascular smooth muscle Br. J. Pharmacol. 113 1994 1538 1547
26. G. Edwards, and A.H. Weston The role of potassium channels in excitable cells Diabetes Res. Clin. Pract. 28 1995 S57 S66 (Suppl.)
27. J.H. Sheldon, N.W. Norton, and T.M. Argentieri Inhibition of guinea pig detrusor contraction by NS-1619 is associated with activation of BKCa and inhibition of calcium currents J. Pharmacol. Exp. Ther. 283 1997 1193 1200